Benitec Biopharma Inc. Successfully Closes $18 Million Public Offering: A Milestone for Growth and Innovation

The Exciting News from Benitec Biopharma Inc. By: Anonymous On September 16, 2022, Benitec Biopharma Inc. made a groundbreaking announcement. The development-stage biotechnology company, known for its innovative gene therapy-focused approach, revealed that it recently closed a successful underwritten public offering. This offering included nearly 30 million shares of its common stock, resulting in a…

Read More

ECB’s de Guindos: Eurozone’s Sluggishness No Match for Inflation-Fighting Powers (But Don’t Worry, We Got This)

Is the Eurozone Economic Slowdown Enough to Control Inflation? A Look at ECB’s de Guindos Statement Witty, conversational, and delightfully offbeat, ECB Vice-President Luis de Guindos recently shared his thoughts in an interview on the current economic situation in the Eurozone. According to de Guindos, the Eurozone’s economic slowdown – or possibly recession – will…

Read More

Innovative Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Irish Government

MeiraGTx’s Industry-Leading Gene Therapy Manufacturing Manufacturing Facilities Accelerating Advanced Medicines LONDON and NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ: MGTX) MeiraGTx Holdings plc is revolutionizing the gene therapy manufacturing industry with its state-of-the-art facilities built to accelerate the development and delivery of advanced medicines to patients. The company has implemented…

Read More

Churchill Downs Incorporated: Expanding Horizons with Acquisition of Ellis Park in Henderson, Kentucky

Churchill Downs Incorporated: Expanding Horizons with Acquisition of Ellis Park in Henderson, Kentucky Description: Acquisition of Historic Thoroughbred Racetrack Affords CDI the Opportunity to Construct Gaming and Entertainment Venue in Owensboro, Kentucky. LOUISVILLE, Ky., Sept. 15, 2022 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) announced today that it has signed a definitive agreement…

Read More

Unveiling the Future of Molecular Imaging: Ashvattha Therapeutics Presents Groundbreaking Preclinical Data on 18FOP-801 PET Tracer at WMIC 2022

Ashvattha Therapeutics Announces Presentations of Preclinical Data on Hydroxyl Dendrimer-Based Imaging and Treatment Regimen in Multiple Sclerosis REDWOOD CITY, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing innovative therapies for neurological diseases, has announced that scientific collaborators at Stanford University will present data on an imaging and treatment regimen…

Read More

Revolutionizing the Art World: MetaWorks Chosen to Create Web3 Auction Platform and Digital Marketplace for the Royal House of Medici

MetaWorks Revolutionizing the Art World MetaWorks Selected to Develop Web3 Art Auction Platform MetaWorks Platforms, Inc. (“MetaWorks”), a leading web3 blockchain platform provider, has been chosen to create a cutting-edge art auction platform and digital marketplace for The Royal House of… Reimagining Renaissance Art MetaWorks is set to revolutionize the art world by providing a…

Read More